Non-healing Wound Clinical Trial
Official title:
A Phase 2 Randomized Study to Compare the Efficacy and Safety of Ultrasonic Drug Delivery to Standard of Care for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Chronic Non-Healing Wounds
This is a randomized study to compare the safety and efficacy of a single dose of up to 2 grams of cefazolin administered using a new drug delivery method called Ultrasonic Drug Delivery (UDD), combined with standard of care (SOC) antibiotic therapy, oral or IV, compared to standard of care (SOC) antibiotic therapy alone, in treating chronic wounds with skin and soft tissue infection, containing gram-positive pathogens, in lower extremities.
This is a Phase 2, single-center, parallel-group study to compare the efficacy and safety of
UDD plus standard of care (SOC) with SOC alone for the treatment of skin and soft tissue
infections in non-healing wounds. After review of screening results to determine eligibility,
a patient will be randomly assigned to one of the two treatments:
Investigational Group: This group will receive administration of a single dose of cefazolin,
using a novel new drug delivery system called Ultrasonic Drug Delivery (UDD), to the site of
infection, combined with SOC, followed by best available adjunct therapy. An optional two
additional treatments will be available if needed.
Comparator Group: This group will receive conventional standard of care treatment followed by
best available adjunct therapy.
Efficacy will be assessed by clinical response based on the presence of vascularized
granulation tissue, reduction of pain, temperature, measurement of lesion size and
temperature, culture and gram stain results, and clinical signs of infection (erythema,
induration/swelling, fluctuance, purulent drainage, warmth/localized heat, and
tenderness/pain). Additionally, efficacy will be assessed by resolution of infection and
microbiological assessments.
Safety will be assessed by reported adverse events, clinical laboratory tests (hematology,
serum chemistry, fasting glucose, hs-CRP), and concomitant medication.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03632031 -
Treatment of Wounds Using Oasis® ECM
|
||
Completed |
NCT03230175 -
Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01)
|
Phase 2 | |
Completed |
NCT04483934 -
Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts
|
Phase 1/Phase 2 | |
Terminated |
NCT04134143 -
Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot Ulcers
|
Phase 1 | |
Recruiting |
NCT04450693 -
Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)
|
Phase 3 | |
Completed |
NCT06442865 -
AMNIODERM+ Medical Device Clinical Study
|
||
Not yet recruiting |
NCT06327113 -
Antibiotic Tumescent For Chronic Wounds
|
Phase 2 | |
Not yet recruiting |
NCT03049670 -
The Use of Klorsept Solution for Debriding Infected Wounds: is it Effective and Safe? Prospective Observational Study
|
N/A | |
Not yet recruiting |
NCT05766982 -
Kerecis Fish Skin Grafts With and Without Platelet Rich Plasma (PRP)
|
N/A | |
Completed |
NCT05921292 -
Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies
|
Early Phase 1 | |
Completed |
NCT04176120 -
Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)
|
Phase 3 | |
Completed |
NCT02657876 -
ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers
|
Phase 1 | |
Not yet recruiting |
NCT06109844 -
FORCEREPAIR - A Wound Exudate Investigation
|
||
Terminated |
NCT04240574 -
Debritom - Micro Water Jet Technology and Wound Healing
|
N/A | |
Completed |
NCT05154838 -
Development of Volatile Organic Compounds (VOC) Analysis as a Potential Diagnostic for Infected and Non-Healing Wounds
|
||
Not yet recruiting |
NCT05251480 -
Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People
|
N/A | |
Completed |
NCT04344483 -
Effect of Lidocaine and Adrenaline Soaked Gauze Versus Normal Saline Soaked at Skin Graft Donor Site of Thigh
|
N/A | |
Recruiting |
NCT05739149 -
A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients With Chronic Ulcers
|
N/A | |
Completed |
NCT03863054 -
An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (NATROX™) on the Rates of Healing of Chronic Diabetic Foot Ulcers
|
||
Recruiting |
NCT06028386 -
Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers
|
N/A |